We are live on ! Find out more
VTAK icon

Catheter Precision

7 hedge funds and large institutions have $10.2M invested in Catheter Precision in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $9.19M → $10.2M (+$1.02M)

0% less ownership

Funds ownership: 0%0% (-0%)

22% less funds holding

Funds holding: 97 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
2
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change

VTAK Hedge Fund Activity: Q2 2019 in Review

7 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q2 2019, worth a combined $10.2M — up 11% from $9.19M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of VTAK and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.

The largest buyer was Alethea Capital Management, adding an estimated $911K. The largest seller was Vanguard Group, exiting entirely with an estimated $911K sold.

  • 7 institutional investors held Catheter Precision (VTAK) as of Q2 2019, down from 9 in Q1 2019.
  • Funds reported $10.2M of Catheter Precision stock for Q2 2019, up 11% quarter-over-quarter.
  • 1 fund opened new Catheter Precision positions in Q2 2019 and 3 closed out, a net change of -2 holders.
  • The largest Catheter Precision buyer in Q2 2019 was Alethea Capital Management, an estimated $911K added.
  • The largest Catheter Precision seller in Q2 2019 was Vanguard Group, an estimated $911K sold.

Based on aggregated 13F filings for Q2 2019.